Showing results (191-200 of 338) with videos related to

Sort By:
Pageof 34
Ophthalmology|January 8, 2014
Intraocular pressure in eyes receiving monthly ranibizumab in 2 pivotal age-related macular degeneration clinical trialsSophie J Bakri, Darius M Moshfeghi, Steve Francom, et al.
European Journal of Ophthalmology|July 30, 2020
Conserved regression patterns of retinopathy of prematurity after intravitreal ranibizumab: A class effectMarco H Ji, Darius M Moshfeghi, Ryan A Shields, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|July 25, 2012
Macular infarction following intravitreal bevacizumab for treatment of central retinal vein occlusionLoh-Shan B Leung, Ruwan A Silva, Mark S Blumenkranz, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 18, 2016
Mobile Health in the Retinal Clinic Population: Access to and Interest in Self-TrackingCassie A Ludwig, Natalia F Callaway, Joyce Ho Park, et al.
Survey of Ophthalmology|May 9, 2026
Retinopathy of prematurity: A global review of screening guidelinesNina Ahmad, Celine Chaaya, Srujay Pandiri, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 24, 2023
Vitreoretinal Specialist Use of Ancillary Testing: An IRIS® Registry AnalysisSaloni Vishwakarma, Durga S Borkar, Andrew LaPrise, et al.
Translational Vision Science & Technology|January 6, 2018
Beyond Retinal Layers: A Deep Voting Model for Automated Geographic Atrophy Segmentation in SD-OCT ImagesZexuan Ji, Qiang Chen, Sijie Niu, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 18, 2016
Multi-Modal Longitudinal Evaluation of Subthreshold Laser Lesions in Human Retina, Including Scanning Laser Ophthalmoscope-Adaptive Optics ImagingEdward H Wood, Theodore Leng, Ira H Schachar, et al.
Retina (Philadelphia, Pa.)|January 28, 2016
THINKING LEAN: Improving Vitreoretinal Clinic Efficiency by Decentralizing Optical Coherence TomographyNatalia F Callaway, Joyce H Park, Jacqueline Maya-Silva, et al.
European Journal of Ophthalmology|November 11, 2021
Ocular adverse events following intravitreal brolucizumab for neovascular age-related macular degeneration at a single tertiary care centerHuy V Nguyen, Angela S Li, Amila R Silva, et al.
Pageof 34